Tong, Van T.

Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis

Allotey, J., Fernandez, S., Bonet, M., Stallings, E., Yap, M., Kew, T., Zhou, D., Coomar, D., Sheikh, J., Lawson, H., et al. (2020) · BMJ

COVID-19 Impact on ReproductionCOVID-19 Clinical Research Studies

Cited by 2,304

Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-October 3, 2020

Zambrano, L. D., Ellington, S., Strid, P., Galang, R. R., Oduyebo, T., Tong, V. T., Woodworth, K. R., Nahabedian, J. F., Azziz-Baumgartner, E., Gilboa, S. M., et al. (2020) · MMWR Morbidity and Mortality Weekly Report

COVID-19 Impact on ReproductionCOVID-19 Clinical Research Studies

Cited by 1,207

Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-June 7, 2020

Ellington, S., Strid, P., Tong, V. T., Woodworth, K., Galang, R. R., Zambrano, L. D., Nahabedian, J., Anderson, K., & Gilboa, S. M. (2020) · MMWR. Morbidity and Mortality Weekly Report

COVID-19 Impact on ReproductionCOVID-19 Clinical Research Studies

Cited by 1,065

Framework for Evaluating Public Health Surveillance Systems for Early Detection of Outbreaks: Recommendations from the CDC Working Group: (548632006-001)

Buehler, J. W., Hopkins, R. S., Overhage, J. M., Sosin, D. M., & Tong, V. T. (2004) · PsycEXTRA Dataset

Data-Driven Disease SurveillancePharmacovigilance and Adverse Drug Reactions

Cited by 473

Maternal mortality and morbidity in the United States: where are we now?

Creanga, A. A., Berg, C. J., Ko, J. Y., Farr, S. L., Tong, V. T., Bruce, F. C., & Callaghan, W. M. (2014) · Journal of Women's Health

Maternal and fetal healthcareGlobal Maternal and Child Health

Cited by 397

Infant Morbidity and Mortality Attributable to Prenatal Smoking in the U.S.

Dietz, P. M., England, L. J., Shapiro-Mendoza, C. K., Tong, V. T., Farr, S. L., & Callaghan, W. M. (2010) · American Journal of Preventive Medicine

Prenatal Substance Exposure EffectsSmoking Behavior and Cessation

Cited by 363

Trends in postpartum depressive symptoms- 27 States, 2004, 2008, and 2012

Ko, J. Y., Rockhill, K. M., Tong, V. T., Morrow, B., & Farr, S. L. (2017) · MMWR. Morbidity and Mortality Weekly Report

Maternal Mental Health During Pregnancy and PostpartumMaternal and Neonatal Healthcare

Cited by 334

Nicotine and the Developing Human

England, L. J., Bunnell, R. E., Pechacek, T. F., Tong, V. T., & McAfee, T. A. (2015) · American Journal of Preventive Medicine

Smoking Behavior and CessationPrenatal Substance Exposure Effects

Cited by 320

Estimates of nondisclosure of cigarette smoking among pregnant and nonpregnant women of reproductive age in the United States

Dietz, P. M., Homa, D., England, L. J., Burley, K., Tong, V. T., Dube, S. R., & Bernert, J. T. (2011) · American Journal of Epidemiology

Smoking Behavior and CessationPrenatal Substance Exposure Effects

Cited by 276

Adverse Birth Outcomes Associated With Prepregnancy and Prenatal Electronic Cigarette Use

Regan, A. K., Bombard, J. M., O’Hegarty, M. M., Smith, R. A., & Tong, V. T. (2021) · Obstetrics & Gynecology

Smoking Behavior and CessationPrenatal Substance Exposure Effects

Cited by 74

Perceptions of emerging tobacco products and nicotine replacement therapy among pregnant women and women planning a pregnancy

England, L. J., Tong, V. T., Koblitz, A., Kish-Doto, J., Lynch, M. M., & Southwell, B. G. (2016) · Preventive Medicine Reports

Smoking Behavior and CessationPrenatal Substance Exposure Effects

Cited by 58